BSX241108C100000
- 0.00
- 0.000.00%
Boston Scientific Newsroom
CCORF Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $98
TD Cowen Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $100
TD Cowen Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $100
A Quick Look at Today's Ratings for Boston Scientific(BSX.US), With a Forecast Between $98 to $100
Boston Scientific Analyst Ratings
BofA Securities Maintains Boston Scientific(BSX.US) With Buy Rating
Boston Scientific (BSX) Gets a Buy From Bank of America Securities
C.L. King Maintains Boston Scientific(BSX.US) With Buy Rating, Raises Target Price to $90
TD Cowen Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $100
Argus Adjusts Price Target on Boston Scientific to $105 From $90
Baird Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $100
Boston Scientific Price Target Maintained With a $98.00/Share by Canaccord Genuity
Boston Scientific Is Maintained at Buy by Canaccord Genuity
A Quick Look at Today's Ratings for Boston Scientific(BSX.US), With a Forecast Between $97 to $100
Boston Scientific Analyst Ratings
Mizuho Maintains Outperform on Boston Scientific, Raises Price Target to $110
Analysts Offer Insights on Healthcare Companies: Community Health (CYH), Viking Therapeutics (VKTX) and Boston Scientific (BSX)
Wells Fargo Adjusts Price Target on Boston Scientific to $98 From $87, Maintains Overweight Rating
Needham Sticks to Their Hold Rating for Boston Scientific (BSX)
Boston Scientific's Strong Growth Trajectory Justifies Buy Rating Amid Strategic Advances